Tazidime and Rash macular - a phase IV clinical study of FDA data

Summary:

Rash macular is reported as a side effect among people who take Tazidime (ceftazidime), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Chronic obstructive pulmonary disease.

The phase IV clinical study analyzes which people have Rash macular when taking Tazidime. It is created by eHealthMe based on reports of 10,389 people who have side effects when taking Tazidime from the FDA, and is updated regularly.

What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.

What is Rash macular?

Rash macular (small, flat red spots) is found to be associated with 1,363 drugs and 1,513 conditions by eHealthMe. Check the latest studies of Rash macular.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

10,389 people reported to have side effects when taking Tazidime.
Among them, 34 people (0.33%) have Rash macular.

Could Tazidime cause Rash macular?

Among these 34 people:

How long have people been on Tazidime when they have Rash macular? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Rash macular when taking Tazidime? *

  • female: 34.38 %
  • male: 65.62 %

What is the age of people who have Rash macular when taking Tazidime? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 9.68 %
  • 20-29: 3.23 %
  • 30-39: 6.45 %
  • 40-49: 32.26 %
  • 50-59: 12.9 %
  • 60+: 35.48 %

What are other drugs people take besides Tazidime? *

  1. Vancomycin: 12 people, 35.29%
  2. Methotrexate: 7 people, 20.59%
  3. Furosemide: 6 people, 17.65%
  4. Neupogen: 5 people, 14.71%
  5. Gentamicin: 5 people, 14.71%
  6. Prednisolone: 5 people, 14.71%
  7. Zovirax: 5 people, 14.71%
  8. Alprostadil: 5 people, 14.71%
  9. Vancomycin Hydrochloride: 4 people, 11.76%
  10. Bactrim: 4 people, 11.76%

What are other side effects people have besides Rash macular? *

  1. Fever: 15 people, 44.12%
  2. Rash Erythematous (redness of the skin): 12 people, 35.29%
  3. Epidermal Necrolysis (skin condition that is usually caused by a reaction to drugs): 10 people, 29.41%
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 9 people, 26.47%
  5. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 8 people, 23.53%
  6. Multi-Organ Failure (multisystem organ failure): 8 people, 23.53%
  7. Itching: 8 people, 23.53%
  8. Hypotension (abnormally low blood pressure): 7 people, 20.59%
  9. Dermatitis Bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid): 5 people, 14.71%
  10. Blood Creatinine Increased: 5 people, 14.71%

What are the existing conditions these people have? *

  1. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 8.82%
  2. Pneumonia: 2 people, 5.88%
  3. Endophthalmitis (inflammation of the internal coats of the eye): 2 people, 5.88%
  4. Enterobacter Test Positive: 2 people, 5.88%
  5. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 2 people, 5.88%
  6. Psoriasis (immune-mediated disease that affects the skin): 1 person, 2.94%
  7. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 1 person, 2.94%
  8. Rashes (redness): 1 person, 2.94%
  9. Meningitis Streptococcal (a bacterial infection of the membranes covering the brain and spinal cord (meninges)): 1 person, 2.94%
  10. Systemic Candida (whole body fungal infection): 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Tazidime and have Rash macular?

- Check whether Rash macular is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tazidime:

Rash macular treatments and more:

How severe was Rash macular and when was it recovered:

Expand to all the drugs that have ingredients of ceftazidime:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rash macular:

Browse all the conditions that are associated with Rash macular:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime (the active ingredients of Tazidime) and Tazidime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: